The second phase of human trials of the type-A (H1N1) vaccine, involving 400 volunteers, will be held soon and the results are expected to known by September, Dr Wichai Chokewiwat, chairman of the Government Pharmaceutical Organisation (GPO) said.
The GPO is now recruiting volunteers for the second phase of the flu vaccine trials. So far, 50 people have signed up but only 10 volunteers are allowed to receive the nasal flu vaccine as the researchers found the others had a medical record of contracting the flu virus and the hepatitis virus.
The second phase will be conducted at the Faculty of Tropical Medicine of Mahidol University.
The Nation
